Responding to a query on the impact on pricing with the generics’ entry, he said, “The market will be competitive and evolve ...

Long-defined by high prices, shortages and weekly injections, weight loss drugs including Wegovy and Zepbound are expected to ...

By: Pete Grieve Americans have become so accustomed to price increases year after year that the idea of anything’s cost going ...

The weight loss drug market is bracing itself for a transformative year in 2026, with significant changes anticipated for GLP ...

GLP-1 weight loss drugs such as Ozempic and Wegovy have taken the world by storm. But some side effects, from the accepted - ...

The new year presents a critical juncture for Novo Nordisk, marked by significant investor expectations and mounting pressure. Following a substantial share pri ...

Until now, they've largely been injectable drugs - Ozempic, Wegovy, Mounjaro, Zepbound. They're all weekly shots. The Food and Drug Administration approved the Wegovy pill on December 22. It has the ...

Pharmaceutical companies, telehealth platforms, and digital apps are reshaping how GLP-1 treatments are prescribed, marketed, ...

Danish pharmaceutical firm Novo Nordisk A/S (NYSE:NVO) scored a major win earlier this month after it secured the Food and ...

Despite pressure from the Trump administration, drugmakers are set to hike U.S. prices on 350 medications, including vaccines ...

Novo Nordisk and Eli Lilly are significantly lowering prices of their blockbuster obesity drugs Wegovy and Mounjaro in China, ...